In other words, not every company that makes a drug that qualifies as a new pharmaceutical as defined in the Act for the Development of Biotech and New Pharmaceuticals Industry will necessarily qualify as a biotech firm as defined by the IDB.
換句話說，並非每種合乎《生技新藥條例》的新藥，都能同時符合工業局的「生技」定義。